-+ 0.00%
-+ 0.00%
-+ 0.00%

KAZIA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B TRIAL OF PAXALISIB IN ADVANCED BREAST CANCER

Reuters·06/05/2025 12:00:23

Please log in to view news